Pitti Group Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
1,506
+1
+0.1% +$1.02K 1.32% 21
2026
Q1
$1.38M Buy
1,505
+4
+0.3% +$4.05K 1.12% 25
2025
Q4
$1.61M Sell
1,501
-49
-3% -$46.9K 1.33% 21
2025
Q3
$1.18M Sell
1,550
-66
-4% -$49.1K 1.01% 25
2025
Q2
$1.26M Sell
1,616
-107
-6% -$83.1K 1.09% 23
2025
Q1
$1.42M Buy
1,723
+15
+0.9% +$12.5K 1.46% 19
2024
Q4
$1.32M Buy
1,708
+49
+3% +$40.6K 1.34% 23
2024
Q3
$967K Hold
1,659
1.05% 25
2024
Q2
$967K Sell
1,659
-14
-0.8% -$11.2K 1.05% 25
2024
Q1
$1.27M Buy
1,673
+14
+0.8% +$9.96K 1.42% 22
2023
Q4
$967K Buy
1,659
+1,236
+292% +$721K 1.05% 25
2023
Q3
$227K Buy
+423
New +$218K 0.26% 61

Other funds holding LLY

Pitti Group Wealth Management's LLY Position: Q2 2026 in Review

Pitti Group Wealth Management increased its Eli Lilly (LLY) stake by 0.07% in Q2 2026, buying an estimated $1.02K and bringing the position to 1,506 shares worth $1.81M. The position accounts for 1.32% of the portfolio, ranked #21.

Pitti Group Wealth Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pitti Group Wealth Management held 1,506 shares of Eli Lilly worth $1.81M as of Q2 2026.
  • Pitti Group Wealth Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 1.32% of Pitti Group Wealth Management's portfolio in Q2 2026, its #21 holding.
  • Pitti Group Wealth Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pitti Group Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.